Inclusion of Additional Receipt Dates NOT-CA-03-034
Inclusion of Additional Receipt Dates NOT-CA-02-023

The Biomedical Imaging Program (CIP), of the Division of Cancer Treatment and Diagnosis (DCTD) solicits exploratory/developmental (R21) grants that articulate highly innovative research concepts in diagnostic cancer imaging. Within each area of importance in imaging, there exists a need for innovative and creative approaches leading to new avenues of research. One way to encourage research into high risk/high impact areas is to provide investigators with the initial resources required to accomplish feasibility and pilot testing of innovative ideas. The R21 mechanism will provide investigators at all career levels with a defined level of funding adequate for the initial feasibility testing of high risk/high impact concepts and, if the concepts are viable, for the generation of experimental preliminary data. This would render the investigators competitive for continued funding through other NIH research award mechanisms, thus potentially leading to the establishment of new research programs in areas that might have previously remained unexplored.

• Release Date: December 8, 2000
• Application Receipt Date(s): February 1, June 1, and October 1
• No set aside
• Contact: Anne E. Menkens, Ph.D. (am187k@nih.gov) at 301-435-9024

See full description in NIH Guide: PA-01-030